Related Experiment Video
Updated: Feb 3, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
LDL-apheresis to decrease sFlt-1 during early severe preeclampsia: Report of two cases from a discontinued phase II
Bassam Haddad1, Guillaume Lefèvre2, Alexandra Rousseau3
1CHI Créteil, CRC CHI Créteil, University Paris Est Créteil, Department of Obstetrics and Gynecology, Centre Hospitalier Intercommunal de Créteil, 40 Avenue de Verdun, 94000, Créteil, France.
Low-density lipoprotein (LDL) apheresis did not prolong pregnancies in women with early severe preeclampsia. The trial was stopped early due to safety concerns, indicating this treatment is not yet suitable for extending gestation in preeclampsia.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Cardiovascular Disease
Background:
- Severe preeclampsia can necessitate early delivery, leading to high perinatal mortality before 26 weeks gestation.
- Soluble fms-like tyrosine kinase 1 (sFlt1), an anti-angiogenic factor, is implicated in preeclampsia pathophysiology.
- LDL apheresis has shown potential in reducing sFlt1 levels.
More Related Videos
Related Concept Videos
Decreasing Function
Improper Integrals: Discontinuous Integrands
Decreased Body Temperature
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
Limits with Oscillating Discontinuities
Clinical Trials: Overview

